FI953575A0 - Vesipitoinen lääkekoostumus, jolla on palautuva kuumakovettuva geeliytymisominaisuus - Google Patents

Vesipitoinen lääkekoostumus, jolla on palautuva kuumakovettuva geeliytymisominaisuus

Info

Publication number
FI953575A0
FI953575A0 FI953575A FI953575A FI953575A0 FI 953575 A0 FI953575 A0 FI 953575A0 FI 953575 A FI953575 A FI 953575A FI 953575 A FI953575 A FI 953575A FI 953575 A0 FI953575 A0 FI 953575A0
Authority
FI
Finland
Prior art keywords
pharmaceutical composition
aqueous pharmaceutical
gelling property
reversible thermosetting
application
Prior art date
Application number
FI953575A
Other languages
English (en)
Swedish (sv)
Other versions
FI112778B (fi
FI953575A (fi
Inventor
Masanobu Takeuchi
Hiroe Suzuki
Toshie Takahashi
Hiroki Maruyama
Miyako Sasaki
Keiko Naitou
Touru Oguma
Masayoshi Goto
Original Assignee
Wakamoto Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wakamoto Pharma Co Ltd filed Critical Wakamoto Pharma Co Ltd
Publication of FI953575A0 publication Critical patent/FI953575A0/fi
Publication of FI953575A publication Critical patent/FI953575A/fi
Application granted granted Critical
Publication of FI112778B publication Critical patent/FI112778B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Thermotherapy And Cooling Therapy Devices (AREA)
FI953575A 1993-04-16 1995-07-26 Menetelmä vesipitoisen lääkekoostumuksen valmistamiseksi, jolla on palautuva kuumakovettuva geeliytymisominaisuus FI112778B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP11234593 1993-04-16
JP11234593 1993-04-16
JP9301636 1993-11-10
PCT/JP1993/001636 WO1994023750A1 (en) 1993-04-16 1993-11-10 Reversible, thermally gelling water-base medicinal composition

Publications (3)

Publication Number Publication Date
FI953575A0 true FI953575A0 (fi) 1995-07-26
FI953575A FI953575A (fi) 1995-07-26
FI112778B FI112778B (fi) 2004-01-15

Family

ID=14584369

Family Applications (1)

Application Number Title Priority Date Filing Date
FI953575A FI112778B (fi) 1993-04-16 1995-07-26 Menetelmä vesipitoisen lääkekoostumuksen valmistamiseksi, jolla on palautuva kuumakovettuva geeliytymisominaisuus

Country Status (17)

Country Link
US (1) US5624962A (fi)
EP (1) EP0694310B1 (fi)
KR (1) KR0162025B1 (fi)
CN (1) CN1048393C (fi)
AT (1) ATE189772T1 (fi)
AU (1) AU668447B2 (fi)
CA (1) CA2153234C (fi)
DE (1) DE69327878T2 (fi)
DK (1) DK0694310T3 (fi)
ES (1) ES2141775T3 (fi)
FI (1) FI112778B (fi)
HK (1) HK1017805A1 (fi)
HU (1) HU220864B1 (fi)
IL (1) IL107626A (fi)
NO (1) NO311635B1 (fi)
RU (1) RU2108112C1 (fi)
WO (1) WO1994023750A1 (fi)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6436425B1 (en) 1988-11-16 2002-08-20 Mdv Technologies, Inc. Method and non-gelling composition for inhibiting post-surgical adhesions
US5346703A (en) 1990-08-07 1994-09-13 Mediventures, Inc. Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels
US5318780A (en) * 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
EP0788305B1 (en) * 1994-03-28 2004-11-03 The Trustees of Columbia University in the City of New York Composition for inactivating irritants in fluids
KR100215739B1 (ko) * 1994-10-13 1999-08-16 오쿠다 기요아키 가역성열겔화 수용성 의약 조성물을 함유하는 동결건조 제제
DE19511322C2 (de) 1995-03-28 1999-09-02 Mann Gerhard Chem Pharm Fab Sterile Augengele mit einem Gehalt an mittelkettigen Triglyceriden und Verfahren zu deren Herstellung
US5843470A (en) 1995-10-06 1998-12-01 Mdv Technologies, Inc. Method and composition for inhibiting post-surgical adhesions
CA2232855C (en) * 1997-04-10 2007-10-09 Roche Consumer Health (Worldwide) Sa Pharmaceutical formulation
CA2289618A1 (en) * 1997-05-14 1998-11-19 Shin-Ichi Yasueda Aqueous suspension preparations with excellent redispersibility
EP1039932A1 (en) * 1997-12-23 2000-10-04 Alliance Pharmaceutical Corporation Methods and compositions for the delivery of pharmaceutical agents and/or the prevention of adhesions
US6197347B1 (en) 1998-06-29 2001-03-06 Andrx Pharmaceuticals, Inc. Oral dosage for the controlled release of analgesic
ES2155027B1 (es) * 1999-05-24 2001-12-01 Univ Pais Vasco Geles para propositos multiples, reversibles y degradables.
EP1185309B1 (en) * 1999-06-11 2006-10-04 Cytyc Corporation Liquid gel composition for mapping a breast milk duct prior to surgical excision of the duct or other breast tissue
US6576224B1 (en) * 1999-07-06 2003-06-10 Sinuspharma, Inc. Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
US20020061281A1 (en) * 1999-07-06 2002-05-23 Osbakken Robert S. Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
JP2001158750A (ja) * 1999-12-02 2001-06-12 Lion Corp 眼科用組成物及び抗アレルギー薬の持続性向上方法
JP3450805B2 (ja) 2000-08-08 2003-09-29 わかもと製薬株式会社 水性医薬組成物
US7420030B2 (en) 2000-09-08 2008-09-02 The Board Of Regents Of The University Of Texas System Aminopeptidase A (APA) targeting peptides for the treatment of cancer
US6572849B2 (en) * 2000-09-20 2003-06-03 Lee Shahinian, Jr. Self-preserved antibacterial nasal, inhalable, and topical ophthalmic preparations and medications
JP4820024B2 (ja) * 2001-01-10 2011-11-24 昭和薬品化工株式会社 局所麻酔用組成物
WO2003007979A1 (en) * 2001-07-18 2003-01-30 Board Of Regents, The University Of Texas System An anti-angiogenic state in mice and humans with retinal photorecptor cell degeneration
US20040048243A1 (en) * 2001-09-07 2004-03-11 Wadih Arap Methods and compositions for in vitro targeting
US6846846B2 (en) 2001-10-23 2005-01-25 The Trustees Of Columbia University In The City Of New York Gentle-acting skin disinfectants
US7879365B2 (en) * 2002-02-07 2011-02-01 The Trustees Of Columbia University In The City Of New York Zinc salt compositions for the prevention of dermal and mucosal irritation
JP4651944B2 (ja) 2002-02-07 2011-03-16 ザ トラスティース オブ コロンビア ユニバーシティ イン ザ シティ オブ ニューヨーク 殺***剤および殺菌剤からの粘膜刺激の予防のための亜鉛塩組成物
US7745425B2 (en) 2002-02-07 2010-06-29 The Trustees Of Columbia University In The City Of New York Non-irritating compositions containing zinc salts
EP1484054B1 (en) * 2002-02-22 2012-08-29 Santen Pharmaceutical Co., Ltd. Drug delivery system for the subconjunctival administration of fine grains
US20030211173A1 (en) * 2002-05-08 2003-11-13 Veach Tom C. Lubrication composition
AU2003264498A1 (en) * 2002-09-18 2004-04-08 Wakamoto Pharmaceutical Co., Ltd. Transparent and reversibly heat-gelling aqueous compositions
US7220431B2 (en) 2002-11-27 2007-05-22 Regents Of The University Of Minnesota Methods and compositions for applying pharmacologic agents to the ear
JP2004196787A (ja) * 2002-12-04 2004-07-15 Santen Pharmaceut Co Ltd 結膜下デポによるドラッグデリバリーシステム
WO2004052399A1 (ja) * 2002-12-10 2004-06-24 Showa Yakuhin Kako Co., Ltd. 局所麻酔用組成物
US20050085446A1 (en) * 2003-04-14 2005-04-21 Babu M.K. M. Fluoroquinolone formulations and methods of making and using the same
JP4669960B2 (ja) * 2003-06-03 2011-04-13 株式会社 メドレックス 局所麻酔薬を含有する口中用または咽頭部用製剤
JP2007534620A (ja) 2003-07-17 2007-11-29 ザ トラスティース オブ コロンビア ユニバーシティ イン ザ シティ オブ ニューヨーク 第４級アンモニウム化合物と精油および／またはその構成要素の相乗的組合せを含む抗菌組成物
WO2005018608A1 (ja) * 2003-08-20 2005-03-03 Santen Pharmaceutical Co., Ltd. 微粒子テノン嚢下投与ドラッグデリバリーシステム
FR2860718B1 (fr) * 2003-10-09 2006-02-24 Jean Pascal Conduzorgues Nouvelle formulation et ses applications dans le domaines cosmetiques ou pharmaceutiques
JP2007517806A (ja) * 2004-01-15 2007-07-05 オーラル バイオサイエンス ピーティーワイ． リミテッド 口腔用麻酔ゲル
US7658947B2 (en) * 2004-06-25 2010-02-09 Kimberly-Clark Worldwide, Inc. Thermo-gelling composition
JP2007277095A (ja) * 2004-07-02 2007-10-25 Wakamoto Pharmaceut Co Ltd アジスロマイシン含有可逆性熱ゲル化水性組成物
US7459416B2 (en) * 2004-07-12 2008-12-02 Panasonic Corporation Fluid bearing unit and spindle motor using the same
CN101175474B (zh) 2005-03-10 2011-09-07 3M创新有限公司 降低微生物污染的方法
JP4979258B2 (ja) * 2005-04-08 2012-07-18 ロート製薬株式会社 アシタザノラスト含有水性組成物
CN100463668C (zh) * 2005-05-09 2009-02-25 凌沛学 可逆性热凝胶化水性药物组合物
CN100430069C (zh) * 2005-07-28 2008-11-05 凌沛学 一种中药及其复方的可逆性热凝胶化水性药物组合物
CN101291671B (zh) * 2005-10-17 2011-02-02 兴和株式会社 含有吲哚美辛的外用液剂
EA008737B1 (ru) * 2005-12-07 2007-08-31 Леонид Андреевич Кожемякин Средство для профилактики и лечения конъюнктивитов и кератитов различной этиологии (варианты), способ его применения
US7759327B2 (en) 2006-01-06 2010-07-20 The Trustees Of Columbia University In The City Of New York Compositions containing zinc salts for coating medical articles
US20070249546A1 (en) * 2006-04-22 2007-10-25 Sawaya Assad S Ophthalmic and related aqueous solutions containing antifungal agents, uses therefor and methods for preparing them
US20080108674A1 (en) * 2006-05-01 2008-05-08 Enturia, Inc. Cationic antiseptic and dye formulation
US20070254854A1 (en) * 2006-05-01 2007-11-01 Medi-Flex, Inc. Aqueous Antiseptic Solution and Compatible Anionic Dye for Staining Skin
US20070253909A1 (en) * 2006-05-01 2007-11-01 Medi-Flex, Inc. Aqueous Antiseptic Solution and Compatible Cationic Dye for Staining Skin
TW200808375A (en) * 2006-05-12 2008-02-16 Otsuka Pharma Co Ltd Hydrogel suspension and manufacturing process thereof
EA014780B1 (ru) * 2007-01-05 2011-02-28 Промед Экспортс Пвт. Лтд. Офтальмическая композиция
DE102007002073A1 (de) * 2007-01-09 2008-07-10 Matthias Habenicht Mittel zur Pflege und antimikrobiellen Behandlung der Haut
WO2009001899A1 (ja) * 2007-06-26 2008-12-31 Wakamoto Pharmaceutical Co., Ltd. 水性組成物
WO2009028674A1 (ja) * 2007-08-29 2009-03-05 Wakamoto Pharmaceutical Co., Ltd. ラタノプロスト含有水性医薬組成物
WO2009074853A2 (en) * 2007-12-10 2009-06-18 Promed Research Centre Ophthalmic composition comprising phenylephrine
KR101534422B1 (ko) * 2008-05-14 2015-07-09 오토노미, 인코포레이티드 귀 질환 치료를 위한 제어 방출형 코르티코스테로이드 조성물 및 방법
US10517839B2 (en) * 2008-06-09 2019-12-31 Cornell University Mast cell inhibition in diseases of the retina and vitreous
TW201023912A (en) * 2008-12-05 2010-07-01 Alcon Res Ltd Pharmaceutical suspension
US20100226992A1 (en) * 2009-03-03 2010-09-09 Alcon Research, Ltd. Pharmaceutical Composition for Delivery of Receptor Tyrosine Kinase Inhibiting (RTKi) Compounds to the Eye
CA2753690A1 (en) * 2009-03-03 2010-09-10 Alcon Research, Ltd. Pharmaceutical composition for delivery of receptor tyrosine kinase inhibiting (rtki) compounds to the eye
WO2010101989A1 (en) * 2009-03-03 2010-09-10 Alcon Research, Ltd. PHARMACEUTICAL COMPOSITION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE
US8299079B2 (en) 2009-05-22 2012-10-30 Kaufman Herbert E Preparations and methods for ameliorating or reducing presbyopia
WO2010135731A1 (en) * 2009-05-22 2010-11-25 Kaufman Herbert E Preparations and methods for ameliorating or reducing presbyopia
KR20130100273A (ko) 2010-08-27 2013-09-10 와카모토 세이야꾸 가부시끼가이샤 점안용 수성 조성물
TWI544922B (zh) 2011-05-19 2016-08-11 愛爾康研究有限公司 高濃度歐羅派特錠（ｏｌｏｐａｔａｄｉｎｅ）眼用組成物
WO2013169458A1 (en) * 2012-05-11 2013-11-14 Bausch & Lomb Incorporated Pharmaceutical compositions and methods for treating, controlling, ameliorating, or reversing conditions of dry eye
RU2485939C1 (ru) * 2012-06-19 2013-06-27 Станислав Анатольевич Кедик Офтальмологический препарат в виде глазных капель, содержащий дисульфирам и таурин
US10507245B2 (en) * 2012-07-19 2019-12-17 Luis Felipe Vejarano Restrepo Ophthalmic formulation and method for ameliorating presbyopia
RU2517033C1 (ru) * 2013-03-05 2014-05-27 федеральное государственное бюджетное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения Российской Федерации Композиция для комплексного лечения больных с первичной открытоугольной глаукомой и заболеваниями глазной поверхности
CN103239390B (zh) * 2013-05-15 2014-08-06 中国人民解放军第三军医大学第二附属医院 托吡卡胺眼用温度敏感原位凝胶及其制备方法
RU2016122224A (ru) * 2013-12-20 2017-12-11 Дзе Проктер Энд Гэмбл Компани Стабильное жидкое лекарственное средство, содержащее дифенгидрамин
JP6714247B2 (ja) * 2017-10-06 2020-06-24 有限会社ジーエヌコーポレーション 尿道狭窄治療剤および尿道狭窄治療方法
WO2019230750A1 (ja) * 2018-05-29 2019-12-05 学校法人 神野学園 外用組成物
US20220008336A1 (en) * 2018-11-26 2022-01-13 Aiviva Biopharma, Inc. Pharmaceutical biodissolvable gels for drug delivery

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3311577A (en) * 1965-03-29 1967-03-28 Burton Parsons Chemicals Inc Underwater contact lens solution
US4188373A (en) * 1976-02-26 1980-02-12 Cooper Laboratories, Inc. Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes
US4100271A (en) * 1976-02-26 1978-07-11 Cooper Laboratories, Inc. Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes
DE2714065A1 (de) * 1977-03-30 1978-10-12 Boehringer Mannheim Gmbh Instillationszubereitung
US4474752A (en) * 1983-05-16 1984-10-02 Merck & Co., Inc. Drug delivery system utilizing thermosetting gels
US4474753A (en) * 1983-05-16 1984-10-02 Merck & Co., Inc. Topical drug delivery system utilizing thermosetting gels
US4474751A (en) * 1983-05-16 1984-10-02 Merck & Co., Inc. Ophthalmic drug delivery system utilizing thermosetting gels
US4478822A (en) * 1983-05-16 1984-10-23 Merck & Co., Inc. Drug delivery system utilizing thermosetting gels
FR2588189B1 (fr) * 1985-10-03 1988-12-02 Merck Sharp & Dohme Composition pharmaceutique de type a transition de phase liquide-gel
GB2203039B (en) * 1987-03-02 1990-10-24 American Cyanamid Co Stable ophthalmic preparations containing acetazolamide
US5252318A (en) * 1990-06-15 1993-10-12 Allergan, Inc. Reversible gelation compositions and methods of use
US5077033A (en) * 1990-08-07 1991-12-31 Mediventures Inc. Ophthalmic drug delivery with thermo-irreversible gels of polxoxyalkylene polymer and ionic polysaccharide
MX9200339A (es) * 1991-01-28 1992-08-01 Hoechst Ag Preparado para la liberacion controlada de sustancias activas, que son apropiadas como terapeuticos o para mejorar el crecimiento y el aprovechamiento de los piensos en rumiantes
AU679937B2 (en) * 1992-11-18 1997-07-17 Johnson & Johnson Consumer Products, Inc. Extrudable compositions for topical or transdermal drug delivery

Also Published As

Publication number Publication date
CA2153234C (en) 1999-02-16
FI112778B (fi) 2004-01-15
KR0162025B1 (ko) 1998-12-01
ATE189772T1 (de) 2000-03-15
NO953189D0 (no) 1995-08-14
ES2141775T3 (es) 2000-04-01
NO311635B1 (no) 2001-12-27
HUT71676A (en) 1996-01-29
DE69327878T2 (de) 2000-06-15
HK1017805A1 (en) 1999-11-26
CN1097593A (zh) 1995-01-25
CA2153234A1 (en) 1994-10-27
AU5433394A (en) 1994-11-08
EP0694310B1 (en) 2000-02-16
HU220864B1 (en) 2002-06-29
IL107626A0 (en) 1994-02-27
EP0694310A1 (en) 1996-01-31
KR960700075A (ko) 1996-01-19
RU2108112C1 (ru) 1998-04-10
IL107626A (en) 1997-09-30
AU668447B2 (en) 1996-05-02
CN1048393C (zh) 2000-01-19
EP0694310A4 (en) 1996-04-24
HU9502086D0 (en) 1995-09-28
US5624962A (en) 1997-04-29
DK0694310T3 (da) 2000-06-05
NO953189L (no) 1995-08-14
FI953575A (fi) 1995-07-26
DE69327878D1 (de) 2000-03-23
WO1994023750A1 (en) 1994-10-27

Similar Documents

Publication Publication Date Title
FI953575A0 (fi) Vesipitoinen lääkekoostumus, jolla on palautuva kuumakovettuva geeliytymisominaisuus
SE8203906D0 (sv) Nytt bandage for administration av lekemedel
ATE167629T1 (de) Arzneimittel mit verzögerter freigabe
ATE74519T1 (de) Waessrige loesung von fettloeslichen wirkstoffen.
ES2067231T3 (es) Formas de dosificado para suministrar un agente antiparkinson.
EP0386960A3 (en) Pharmaceutical compositions useful as drug delivery vehicles and/or as wound dressings
ATE451096T1 (de) Peptidderivate oder deren pharmazeutisch annehmbare salze, verfahren zu deren herstellung, verwendung dieser derivate und arzneimittel
HK48897A (en) An external analgesic lotion and method of making
DE69327432T2 (de) Heilmittel für wunden und hämorrhoiden
BR0306501A (pt) Método para uso e produção de um tampão com medicamento
CY1110078T1 (el) Παρασκευασματα με ιωδιουχο ποβιδονη για την αγωγη τραυματων
MY107088A (en) Plaster used as therapeutic system for the administration of active substances to the skin, which exhibits a graduated active substance release,process for the production of the plaster and use thereof
YU49390A (sh) Postupak za izradu transdermalnog terapijskog sistema sa stupnjevitim otpuštanjem aktivne materije
SE8501312D0 (sv) Etoposide oral dosage form
ATE173405T1 (de) Arzneimittel auf basis von hyaluronsäure
DE69228686D1 (de) Topisch anzuwendendes arzneimittel enthaltend penciclovir
ATE203903T1 (de) Delta-aminolävulinsäure enthaltendes arzneimittel
IT1214658B (it) Esteri polisaccaridici e loro sali
KR927003530A (ko) 이온삼투요법용 제약 제제의 제조에 있어서의 국소 마취제의 용도
IT1275987B1 (it) Composizione farmaceutica attiva nella cura di affezioni dermatologiche
BG51774A1 (en) Pharmaceutical formulation basedon 4-hydroxy-2-methyl-2h-1,2-benzothiazine-3-/n-2-pyridylcarboxamide/ -1,1-dioxide
SE8804285D0 (sv) Anvaendning av dihydroergotamin foer behandling av foerhoejt intrakraniellt tryck

Legal Events

Date Code Title Description
MM Patent lapsed